Relationship between p27^<Kip1> expression and tumor differention and prognosis in human oral squamous cell carcinoma.

人口腔鳞癌p27^<Kip1>表达与肿瘤分化及预后的关系。

基本信息

  • 批准号:
    11671990
  • 负责人:
  • 金额:
    $ 0.45万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

We have investigated the expression of p27^<Kip1> in oral squamous cell carcinomas (OSCCs) using immunohistochemistry and have tried to investigate the relationship between each expression level and clinico-pathological characteristics such as tumor grade, T, N, stage classifications, effect and outcome. High levels of p27^<Kip1> expression were significantly related to well differentiated cases(p<0.05), NO cases (p<0.01), non advanced cases (p<0.01), and good effective cases (p<0.05). Five-year survival rate of p27^<Kip1> high expression cases was 63.3%, and it was significantly high than that of p27^<Kip1> low expression cases (45.5%) (p<0.05). By Cox's proportional hazards model, high levels of p27^<Kip1> expression significantly made the rate of death decrease. These results suggested that p27^<Kip1> protein expression may be closely related to tumor grade, inhibition of metastasis, effect and outcome, and an useful prognostic marker. Next, we have constructed p27^<Kip1> expression vectors with pcDNA3.1 (stratagene). Moreover, we transfected them to OSCC cell line (B88) in sense or anti-sense oriented, and tried to regulate the p27^<Kip1> gene in B88 cells. Overexpression of p27^<Kip1> in B88 cells (B88/Tp27sense) inhibited the growth, invasion and metastasis of them. Contradictory, low expression of p27^<Kip1> in B88 cells (B88/Tp27anti-sense) promoted the growth, invasion and metastasis. On tumor differentiation, we could detect the morphological change from squamous cell type to spindol cell type in B88/Tp27anti-sense though we could not detect the difference between parental B88 and B88/Tp27sense by HE staining. Moreover, we could detect the induction of involucrin and keratin 7,8 (Cam 5.2) in B88/Tp27sense immunohistochemically. These results suggested that p27^<Kip1> might be related to terminal differentiation of OSSC.
我们采用免疫组化方法研究了p27 ~(1-x)<Kip1>在口腔鳞状细胞癌(OSCC)中的表达,并试图探讨其表达水平与临床病理特征如肿瘤分级、T、N、分期、疗效和预后的关系。p27 ~+高表达<Kip1>与高分化癌(p&lt;0.05)、无分化癌(p&lt;0.01)、非晚期癌(p&lt;0.01)和有效癌(p&lt;0.05)有关。p27高表达组5年生存率<Kip1>为63.3%,明显高于p27低<Kip1>表达组的45.5%(P&lt;0.05)。通过考克斯比例风险模型,高水平的p27^<Kip1>表达使死亡率显著降低。提示p27蛋白<Kip1>表达与肿瘤分级、转移抑制、疗效及预后密切相关,是一种有用的预后指标。接下来,我们<Kip1>用pcDNA3.1(stratagene)构建了p27 α表达载体。并将其以正、反义方向转染口腔鳞癌细胞系B88,尝试对B88细胞中p27 ~<Kip1>+基因进行调控。在B88细胞中过表达p27 ~+<Kip1>(B88/Tp 27正义)可抑制B88细胞的生长、侵袭和转移。相反,在B88细胞中,p27 ~(TM)的低表达<Kip1>(B88/Tp 27反义)促进生长、侵袭和转移。在肿瘤分化方面,尽管B88/Tp 27反义组与亲本B88/Tp 27反义组之间的差异在HE染色上没有显示,但我们可以检测到B88/Tp 27反义组的肿瘤细胞由鳞状细胞型向spindol细胞型的形态学变化。此外,我们还可以通过化学方法检测到B88/Tp 27正义链中外皮蛋白和角蛋白7,8(Cam5.2)的诱导。提示p27 ~+<Kip1>可能与OSSC的终末分化有关。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Carlile J: "VEGF expression in oral tissues, Possible relevance to angiogenesis, tumour progression and field cancerisation."J Oral Pathol Med. (in press).
Carlile J:“口腔组织中的 VEGF 表达,可能与血管生成、肿瘤进展和局部癌化相关。”J Oral Pathol Med。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Harada K, Lu S, Chisholm MD, Syrjnen S and Schor AM: "Angiogenesis and vasodilation in skin warts. Association with HPV infection."Anticancer Res. 20. 4519-4524 (2000)
Harada K、Lu S、Chisholm MD、Syrjnen S 和 Schor AM:“皮肤疣中的血管生成和血管舒张。与 HPV 感染的关联。”抗癌研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Motegi K: "Effect of a mutant form of 1kB-α on 5-fluorouracil-induced apoptosis in transformed human salivary gland cells."Oral Oncol, Eur J Cancer. 37. 185-192 (2001)
Motegi K:“1kB-α 突变体对转化人唾液腺细胞中 5-氟尿嘧啶诱导的细胞凋亡的影响。”Oral Oncol,Eur J Cancer 37. 185-192 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Harada K and Ogden GR: "An overview of the cell cycle arrest protein p21^<WAF1>"Oral Oncol, Eur J Cancer. 36. 3-7 (2000)
Harada K 和 Ogden GR:“细胞周期阻滞蛋白 p21^<WAF1> 的概述”Oral Oncol,Eur J Cancer。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Carlile J, Harada K, Baillie R, Macluskey M, Chisholm DM, Ogden GR, Schor SL, Schor AM: "VEGF expression in oral tissues. Possible relevance to angiogenesis, tumour progression and field cancerisation."J Oral Pathol Med. 30 (in press).
Carlile J、Harada K、Baillie R、Macluskey M、Chisholm DM、Ogden GR、Schor SL、Schor AM:“口腔组织中的 VEGF 表达。可能与血管生成、肿瘤进展和局部癌化相关。”J Oral Pathol Med。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HARADA Koji其他文献

HARADA Koji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HARADA Koji', 18)}}的其他基金

Development of novel treatment against refractory oral cancer by uptake inhibition of iron or induction of ferroptosis
通过抑制铁的摄取或诱导铁死亡来开发针对难治性口腔癌的新疗法
  • 批准号:
    18K09814
  • 财政年份:
    2018
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of new oral cancer treatments focused on mTOR inhibition leading to the anti-aging prevention and the healthy life-span extension
开发新的口腔癌治疗方法,重点关注 mTOR 抑制,从而实现抗衰老预防和健康寿命延长
  • 批准号:
    15K11292
  • 财政年份:
    2015
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel functional preservation therapy against advanced, recurrent or unresectable oral cancers.
开发一种针对晚期、复发性或不可切除口腔癌的新型功能保留疗法。
  • 批准号:
    24593034
  • 财政年份:
    2012
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Examination of the physical pictures of the field theories with nonlinearly realized symmetries by the Wilsonian renormalization group method
用威尔逊重正化群方法检验具有非线性实现对称性的场论的物理图像
  • 批准号:
    22540286
  • 财政年份:
    2010
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A fundamental research on a new AIDS treatment based on an error rate control of HIV-1 reverse transcriptase
基于HIV-1逆转录酶错误率控制的艾滋病新疗法的基础研究
  • 批准号:
    22500273
  • 财政年份:
    2010
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new predictive factors for chemo-radiation against oral cancers and setting of individualized medicine based on their expressions
口腔癌放化疗新预测因素的鉴定以及基于其表达的个体化医疗设置
  • 批准号:
    21592555
  • 财政年份:
    2009
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the therapy for oral cancer by S-1 and proteasome inhibitor in combination with concurrent radiotherapy
S-1和蛋白酶体抑制剂联合同步放疗治疗口腔癌的进展
  • 批准号:
    19592339
  • 财政年份:
    2007
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding a mechanism of HIV-1 drug resistance development under the RTI pressure and the development of a medication scheduling system
了解RTI压力下HIV-1耐药性发展的机制以及药物调度系统的开发
  • 批准号:
    18700293
  • 财政年份:
    2006
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of molecular targeting therapy against stability of p27^<Kip1> protein in oral squamous cell carcinoma.
针对口腔鳞状细胞癌中 p27^<Kip1> 蛋白稳定性的分子靶向治疗的发展。
  • 批准号:
    17592089
  • 财政年份:
    2005
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of molecular targeting therapy against p27^<Kip1> in oral squamous cell carcinoma.
口腔鳞状细胞癌中针对 p27^<Kip1> 的分子靶向治疗的发展。
  • 批准号:
    15592116
  • 财政年份:
    2003
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Analysis of the antioxidant function of xCT in lymphatic endothelial cells and its significance in oral squamous cell carcinoma.
淋巴管内皮细胞xCT抗氧化功能分析及其在口腔鳞癌中的意义
  • 批准号:
    23K16139
  • 财政年份:
    2023
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Search for therapeutic target molecules based on temporal hierarchical analysis of Oral squamous cell carcinoma and functional RNA molecules
基于口腔鳞状细胞癌和功能RNA分子的时间层次分析寻找治疗靶分子
  • 批准号:
    23K16142
  • 财政年份:
    2023
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating a new vulnerability in oral squamous cell carcinoma
研究口腔鳞状细胞癌的新脆弱性
  • 批准号:
    10714352
  • 财政年份:
    2023
  • 资助金额:
    $ 0.45万
  • 项目类别:
Defining age-associated alterations in oral squamous cell carcinoma
定义口腔鳞状细胞癌与年龄相关的改变
  • 批准号:
    10607387
  • 财政年份:
    2023
  • 资助金额:
    $ 0.45万
  • 项目类别:
The role of serine metabolism on the evolution of oral squamous cell carcinoma
丝氨酸代谢在口腔鳞状细胞癌演变中的作用
  • 批准号:
    10825875
  • 财政年份:
    2023
  • 资助金额:
    $ 0.45万
  • 项目类别:
Spatial regulation of mechanistic target of rapamycin complex 1 (mTORC1) and its role in oral squamous cell carcinoma
雷帕霉素复合物1(mTORC1)机械靶点的空间调控及其在口腔鳞状细胞癌中的作用
  • 批准号:
    10750317
  • 财政年份:
    2023
  • 资助金额:
    $ 0.45万
  • 项目类别:
Mechanisms linking hypoxia, inflammation and chemosensitivity in feline oral squamous cell carcinoma
猫口腔鳞状细胞癌缺氧、炎症和化疗敏感性的相关机制
  • 批准号:
    RGPIN-2019-06898
  • 财政年份:
    2022
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Discovery Grants Program - Individual
The role of NSD1 inactivation in the development and treatment of oral squamous cell carcinoma
NSD1失活在口腔鳞状细胞癌发生和治疗中的作用
  • 批准号:
    10154391
  • 财政年份:
    2022
  • 资助金额:
    $ 0.45万
  • 项目类别:
Analysis of TGF-beta signaling in cancer-associated fibroblasts (CAFs) for invasion of oral squamous cell carcinoma
分析癌症相关成纤维细胞 (CAF) 中 TGF-β 信号通路对口腔鳞状细胞癌侵袭的影响
  • 批准号:
    22K10143
  • 财政年份:
    2022
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The functions of Dkk1 and Dkk3 in oral squamous cell carcinoma -associated with Wnt5a-Ror2 signaling-
Dkk1 和 Dkk3 在口腔鳞状细胞癌中的功能 - 与 Wnt5a-Ror2 信号传导相关 -
  • 批准号:
    22K17208
  • 财政年份:
    2022
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了